Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,473 | 104,060 | 110,257 | 120,888 | 122,617 |
| Marketable Securities | 143,617 | 48,599 | 2,907 | 13,597 | 23,917 |
| Receivables | 7,092 | 8,558 | 10,579 | 6,899 | 5,105 |
| Other current assets | 402 | 269 | 504 | 0 | 365 |
| TOTAL | $191,979 | $166,602 | $128,873 | $145,001 | $155,020 |
| Non-Current Assets | |||||
| PPE Net | 17,492 | 15,124 | 14,270 | 14,251 | 13,969 |
| Investments And Advances | 12,189 | 56,352 | 0 | 0 | 0 |
| Intangibles | 69,937 | 72,996 | 74,539 | 74,957 | 75,164 |
| Other Non-Current Assets | 917 | 917 | 917 | 916 | 921 |
| TOTAL | $100,535 | $145,389 | $89,726 | $90,124 | $90,054 |
| Total Assets | $292,514 | $311,991 | $218,599 | $235,125 | $245,074 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,975 | 4,495 | 4,018 | 5,985 | 3,339 |
| Accrued Expenses | 13,712 | 10,998 | 8,208 | 10,411 | 9,553 |
| Other current liabilities | N/A | N/A | N/A | 379 | 0 |
| TOTAL | $18,635 | $17,479 | $13,715 | $18,122 | $14,260 |
| Non-Current Liabilities | |||||
| Long Term Debt | 571 | 717 | 861 | 1,004 | 1,653 |
| Deferred Revenues | 1,064 | 1,067 | 532 | 470 | 656 |
| Other Non-Current Liabilities | 1,399 | 1,507 | 1,562 | 1,763 | 1,578 |
| TOTAL | $12,229 | $12,781 | $13,824 | $13,769 | $14,240 |
| Total Liabilities | $30,864 | $30,260 | $27,539 | $31,891 | $28,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,924 | 11,921 | 10,464 | 10,453 | 10,426 |
| Common Shares | 2,389 | 2,386 | 2,097 | 2,091 | 2,090 |
| Retained earnings | -461,547 | -441,820 | -423,956 | -410,146 | -396,092 |
| Other shareholders' equity | -4,561 | -1,743 | -360 | 389 | 663 |
| TOTAL | $261,650 | $281,731 | $191,060 | $203,234 | $216,574 |
| Total Liabilities And Equity | $292,514 | $311,991 | $218,599 | $235,125 | $245,074 |